Adjuvant Sufentanil Decreased the EC50 of Epidural Ropivacaine for Labor Analgesia in Healthy Term Pregnancy
Bo Xiang,Jian Yang,Xiaofeng Lei,Jin Yu
DOI: https://doi.org/10.2147/DDDT.S307478
2021-05-19
Abstract:Bo Xiang, 1 Jian Yang, 2 Xiaofeng Lei, 1 Jin Yu 1 1 Department of Anesthesiology, Chongqing Health Center for Women and Children, Chongqing, 401147, People's Republic of China; 2 Department of Anesthesiology, Chongqing Dongnan Hospital, Chongqing, 401336, People's Republic of China Correspondence: Jin Yu Department of Anesthesiology, Chongqing Health Center for Women and Children, No. 120, Longshan Road, Yubei District, Chongqing, 401147, People's Republic of China Tel +86-18623117820 Fax +86-23-63702844 Email Jian Yang Department of Anesthesiology, Chongqing Dongnan Hospital, No. 98, Tongjiang Ave, Nanan District, Chongqing, 401336, People's Republic of China Tel/Fax +86-23-62905685 Email Objective: The optimal concentration of ropivacaine as epidural labor analgesia combined with sufentanil has not been established. This study aimed to determine the median effective concentration (EC50) of epidural ropivacaine for labor analgesia in healthy term pregnancy when co-administered with sufentanil as an adjuvant or alone. Patients and Methods: Sixty healthy parturients scheduled for epidural labor analgesia were enrolled in the study. They were divided into a saline group (Group C) and an epidural sufentanil (0.5 μg/mL) group (Group S). The initial concentration of ropivacaine was set at 0.125%, which was then varied by 0.01% using the up-and-down sequential allocation method. The hemodynamics were continuously monitored during delivery. A visual analog scale was used to evaluate the degree of pain. The Ramsay sedation score, duration of the labor stages, the onset of epidural analgesia, and adverse effects were recorded. Neonatal outcomes were evaluated using the Apgar scores and umbilical artery blood gas analysis. Results: The EC50 of ropivacaine was 0.085% (95% CI, 0.079– 0.090%) in Group S and 0.109% (95% CI, 0.105– 0.112%) in Group C. The EC95 of ropivacaine was 0.096% (95% CI, 0.090– 0.118%) in Group S, and 0.116% (95% CI, 0.113– 0.127%) in Group C. The difference between the groups was statistically significant (p 0.05). Conclusion: The EC50 of ropivacaine was reduced by 22% when co-administered with sufentanil for epidural labor analgesia in primipara. ( www.chictr.org.cn ; registration number: ChiCTR2000039547). Keywords: median effective concentration, ropivacaine, sufentanil, labor analgesia With the recent advances in modern medicine and comfort care, analgesia in labor is increasingly applied in obstetrics. Epidural analgesia for labor is a popular and effective technique because of its reliable performance and quick onset. It works in 95% of the cases by adjusting the anesthetic concentration according to the parturient's condition. 1 , 2 Opioids such as morphine, fentanyl, and sufentanil combined with ropivacaine are commonly used for regional anesthesia to improve the anesthetic effects and reduce the local intrathecal dosage. 3 , 4 Sufentanil, a synthetic opioid, has a favorable analgesic effect and fewer adverse reactions. It has been recommended as an adjuvant with ropivacaine (0.0625–0.15%) for an epidural in the latest expert consensus on epidural labor analgesia. Previous studies demonstrated that sufentanil (0.5 μg/mL) with ropivacaine for labor analgesia could reduce local anesthetic requirements and minimize motor block. 5–8 However, the optimal dose of ropivacaine can be reduced by sufentanil (0.5 μg/mL) is not clear due to the variety of administration methods. Therefore, the present study was designed to determine the median effective concentration (EC50) of epidural ropivacaine for labor analgesia in healthy term pregnancy when co-administered with sufentanil adjuvant or alone using the up-down sequential allocation technology. The study was implemented in accordance with the Declaration of Helsinki and was approved by the Research Ethics Committee of Chongqing Health Center for Women and Children (Number.2020–017). Written informed consent was obtained from all participants. This study was registered with the Chinese Clinical Trial Registry (ChiCTR) ( www.chictr.org ) (registration ID: ChiCTR2000039547). Sixty full-term pregnant women scheduled for vaginal delivery with epidural labor analgesia were enrolled in the study. The inclusion criteria were: (1) 20–35 years old parturient women at 38–42 weeks of single pregnancy; (2) no abortion history; (3) categorized a -Abstract Truncated-